Ye-Seul Kim Selected Research

CU06-1004

1/2023	CU06-1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium.
1/2020	CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction.
1/2020	CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ye-Seul Kim Research Topics

Disease

9	Neoplasms (Cancer) 06/2022 - 01/2015
3	Ovarian Neoplasms (Ovarian Cancer) 10/2015 - 01/2015
2	Diabetes Mellitus 02/2021 - 12/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2015
2	Inflammation (Inflammations) 01/2021 - 01/2020
1	Osteoporotic Fractures 05/2024
1	Osteoporosis 05/2024
1	Ischemic Stroke 07/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2023
1	Headache (Headaches) 07/2023
1	Migraine Disorders (Migraine) 07/2023
1	Hereditary Angioedemas 01/2023
1	Pain (Aches) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2021
1	Colorectal Neoplasms (Colorectal Cancer) 02/2021
1	Insulin Resistance 01/2021
1	Dementia (Dementias) 12/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2020
1	Lung Neoplasms (Lung Cancer) 11/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Hypercholesterolemia 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Colitis 01/2020
1	Diarrhea 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Hyperlipidemias (Hyperlipidemia) 03/2015
1	Fatty Liver 03/2015
1	Coronary Disease (Coronary Heart Disease) 03/2015
1	Prostatic Neoplasms (Prostate Cancer) 05/2014
1	Breast Neoplasms (Breast Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

5	Metformin (Glucophage)FDA LinkGeneric 03/2021 - 01/2020
3	CU06-1004IBA 01/2023 - 01/2020
2	HDL CholesterolIBA 05/2024 - 01/2021
2	LipidsIBA 05/2024 - 03/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2020
2	bisphenol AIBA 10/2015 - 04/2015
2	Estrogen ReceptorsIBA 10/2015 - 04/2015
2	nonylphenolIBA 10/2015 - 04/2015
1	Ergotamine (Ergotamine Tartrate)FDA LinkGeneric 07/2023
1	Tryptamines (Triptans)IBA 07/2023
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	BradykininIBA 01/2023
1	4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butan- 1- olIBA 03/2022
1	CarcinogensIBA 03/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2021
1	C-Reactive ProteinIBA 01/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	CytokinesIBA 01/2020
1	Drinking WaterIBA 01/2020
1	NivolumabIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020
1	Dextrans (Dextran)FDA Link 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Estrogens (Estrogen)FDA Link 10/2015
1	Endocrine DisruptorsIBA 10/2015
1	Phytoestrogens (Phytoestrogen)IBA 10/2015
1	GenisteinIBA 10/2015
1	EnzymesIBA 05/2015
1	ProdrugsIBA 05/2015
1	Fulvestrant (Faslodex)FDA Link 04/2015
1	Palm OilIBA 03/2015
1	Sunflower OilIBA 03/2015
1	OilsIBA 03/2015
1	CholesterolIBA 03/2015
1	Dietary Fats (Dietary Fat)IBA 03/2015
1	VimentinIBA 01/2015
1	RNA (Ribonucleic Acid)IBA 01/2015
1	Cadherins (E-Cadherin)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Caspase 3 (Caspase-3)IBA 05/2014
1	dactolisibIBA 05/2014
1	Ethanol (Ethyl Alcohol)IBA 01/2012
1	Trypan Blue FDA Link 01/2012

Therapy/Procedure

3	Therapeutics 11/2020 - 05/2015
1	Palliative Care (Palliative Therapy) 06/2022
1	Immunotherapy 01/2020